A pilot trial of bright light therapy in patients receiving first line immune checkpoint blockade

The purpose of this study is to evaluate the safety and effectiveness of bright light therapy for patients with melanoma and non-small cell lung cancer (NSCLC).In this study, bright light therapy will be provided via an iPad at the participant's home for 60 minutes total.